Vogel R L
Clin Lab Manage Rev. 1993 Sep-Oct;7(5):442-5.
In its efforts to fight fraud, the government has turned increasingly to the civil False Claims Act. The Act imposes triple damages plus monetary penalties against those who defraud the federal government. The Act also encourages whistleblowers to report fraud by offering the prospect of large bounties. This article describes the False Claims Act, its qui tam provision dealing with whistleblowers, and the application of the Act to clinical laboratories.
为打击欺诈行为，政府越来越多地诉诸《民事欺诈索赔法》。该法案对欺诈联邦政府的人处以三倍损害赔偿及罚款。该法案还通过提供高额赏金的方式鼓励举报人举报欺诈行为。本文介绍了《欺诈索赔法》、其处理举报人的qui tam条款以及该法案在临床实验室中的应用。
